
Alzheimer's Drug Discovery Foundation is a venture capital firm. Based in New York, United States. Known portfolio companies include Astrocyte Pharmaceuticals, ADmit Therapeutics, APRINOIA Therapeutics, CuraSen Therapeutics, BrainScope Company and Superfluid Dx, 11 companies in all.
Is Alzheimer's Drug Discovery Foundation a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechDiagnosticsDrug DiscoveryMedTechNeuroscienceVenture Philanthropy
Contacts
Who to pitch at Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation portfolio companies (11)
- Astrocyte Pharmaceuticals
- ADmit Therapeutics
- APRINOIA Therapeutics
- CuraSen Therapeutics
- BrainScope Company
- Superfluid Dx
- ALZpath
- BrainScope
- GliaPharm
- Imeka
- NeuroAge Therapeutics
Co-investors
Funds that share portfolio companies with Alzheimer's Drug Discovery Foundation.
Similar funds
Showing 20 of 100
About Alzheimer's Drug Discovery Foundation
The firm's listing covers sector Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and MedTech; known deals cluster at Seed, Series A and Series B.
Of the 4 people on file at Alzheimer's Drug Discovery Foundation, Marianne Mertens (Investment Committee Member), Michael Kowalski (Mission-Related Investments Coordinator) and Alan O'Connell (Scientific Advisory Board Member) are listed as the contacts to approach first.
Across the known portfolio, 20 co-investors appear alongside Alzheimer's Drug Discovery Foundation, including Clave Capital, Imm Private Equity and Dreavent.
Frequently asked questions
What is Alzheimer's Drug Discovery Foundation?
Alzheimer's Drug Discovery Foundation is a venture capital firm based in New York, United States, with a known portfolio of 11 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Alzheimer's Drug Discovery Foundation invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and MedTech. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Alzheimer's Drug Discovery Foundation invest at?
The known deals of Alzheimer's Drug Discovery Foundation include Seed, Series A and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Alzheimer's Drug Discovery Foundation?
3 of the 4 people on file at Alzheimer's Drug Discovery Foundation are listed as contacts for the firm. All 4 have their own profile page.
How do I contact Alzheimer's Drug Discovery Foundation?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 4 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
